Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli Lilly ...
Vree TM for Diabetes 2.0 Helps Patients Manage Their Condition and Facilitates Communication with Healthcare Providers Merck today announced the launch of a mobile application designed to be used by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results